You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Trove at the National Library of Australia has information on archived TGA consultations and reviews.
Filters
Status
Categories
- Remove Advertising filter Advertising (2)
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Blood and blood components filter Blood and blood components (0)
- Remove Complementary medicines filter Complementary medicines (7)
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Medical devices safety (1) Apply Medical devices safety filter
- Remove Medicinal cannabis filter Medicinal cannabis (1)
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Remove Prescription medicines filter Prescription medicines (7)
- Scheduling (56) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Medicinal cannabis filter Medicinal cannabis
- (-) Remove Blood and blood components filter Blood and blood components
- (-) Remove Complementary medicines filter Complementary medicines
- (-) Remove Advertising filter Advertising
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
- (-) Remove Prescription medicines filter Prescription medicines
IMDRF consultation: Personalised Medical Devices - Regulatory Pathways
Closed on 24 July 2019
Proposed new classification rule for medical devices that administer medicines or biologicals by inhalation
Closed on 29 April 2019
Proposed medical device classification for human cells, tissues and organs storage solutions and IVF media
Closed on 29 April 2019
Proposed new medical device classification for substances introduced into the body via a body orifice or applied to the skin
Closed on 29 April 2019
Proposed changes to the classification of active implantable medical devices and their accessories
Closed on 29 April 2019
Proposed changes to the classification of medical devices used in direct contact with the heart, central circulatory or central nervous systems
Closed on 29 April 2019
Proposed reclassification of spinal implantable medical devices
Closed on 31 March 2019
Regulation of software, including Software as a Medical Device (SaMD)
Closed on 31 March 2019
Proposed regulatory scheme for personalised medical devices, including 3D-printed devices
Closed on 31 March 2019
Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia
Closed on 18 February 2019